Skip to Main Content

Paper Details

Nicotinamide-N-methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma.
Clin Transl Med
18
2022
Author NameAffiliation
Arnulf StenzlUniversity Hospital Tuebingen
Matthias Schwab
Matthias SchwabUniversity of Tuebingen
Matthias SchwabGerman Cancer Research Center (DKFZ)
Matthias SchwabUniversity of Tuebingen
Matthias SchwabUniversity of Tuebingen
  • 1 - 6

Datasets

Release 1.2